DLX3 Antibody
Référence MBS8582215-0,1mL-HRP
Conditionnement : 0.1mL(HRP)
Marque : MyBiosource
DLX3 Antibody – Rabbit Polyclonal
For Research Use Only. Not for use in diagnostic procedures. Catalog #: MBS8582215MBS8582215 is an antibody targeting DLX3. Also known as DLX3 Antibody. Reactive in Human, Mouse, Rat, Bovine, Dog, Pig, Sheep. Host: Rabbit. Rabbit polyclonal antibody to DLX3 More details
Product Overview
Online Datasheet in PDFProduct Name
DLX3, Polyclonal Antibody
Full Product Name
DLX3 Antibody
Product Gene Name
anti-DLX3 antibody
Product Synonym Names
Homeobox protein DLX-3
Clonality
Polyclonal
Isotype
IgG
Host
Rabbit
Species Reactivity
Human, Mouse, Rat, Bovine, Dog, Pig, Sheep
Form/Format
Liquid in 0.42% Potassium phosphate, 0.87% Sodium chloride, pH7.3, 30% glycerol, and 0.01% sodium azide.
Purity/Purification
The antibody was purified by immunogen affinity chromatography.
Specificity
Recognizes endogenous levels of DLX3 protein.
Preparation and Storage
Shipped at 4 degree C. Upon delivery aliquot and store at -20 degree C for one year. Avoid freeze/thaw cycles.
Molecular Weight
31,738 Da
Chromosome Location
Chromosome: 17; NC_000017.10 (48067369..48072588, complement). Location: 17q21
OMIM
104510
Immunogen
KLH-conjugated synthetic peptide encompassing a sequence within the center region of human DLX3. The exact sequence is proprietary.
Product Categories/Family for anti-DLX3 antibody
Primary Antibody
ISO Certification
Manufactured in an ISO 9001:2015 Certified Laboratory.
Applications Tested/Suitable for anti-DLX3 antibody
Western Blot (WB), Immunohistochemistry (IHC), Immunofluorescence (IF), Immunocytochemistry (ICC)
Application Notes for anti-DLX3 antibody
WB: 1:500-1:1000
IHC: 1:50-1:200
IHC: 1:50-1:200
Other Notes
Small volumes of anti-DLX3 antibody vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.
Additional Details
NCBI/Uniprot data below describe general gene information for DLX3. It may not necessarily be applicable to this product.
UniProt Primary Accession #
UniProt Secondary Accession #
UniProt Related Accession #
GenBank Nucleotide #
NCBI Official Full Name
homeobox protein DLX-3
NCBI Official Synonym Full Names
distal-less homeobox 3
NCBI Official Symbol
DLX3
NCBI Official Synonym Symbols
AI4; TDO
UniProt Protein Name
Homeobox protein DLX-3
Protein Family
Distal-less-like protein
UniProt Gene Name
DLX3
UniProt Entry Name
DLX3_HUMAN
NCBI Protein Information
homeobox protein DLX-3
NCBI Summary for DLX3
Many vertebrate homeo box-containing genes have been identified on the basis of their sequence similarity with Drosophila developmental genes. Members of the Dlx gene family contain a homeobox that is related to that of Distal-less (Dll), a gene expressed in the head and limbs of the developing fruit fly. The Distal-less (Dlx) family of genes comprises at least 6 different members, DLX1-DLX6. Trichodentoosseous syndrome (TDO), an autosomal dominant condition, has been correlated with DLX3 gene mutation. This gene is located in a tail-to-tail configuration with another member of the gene family on the long arm of chromosome 17. Mutations in this gene have been associated with the autosomal dominant conditions trichodentoosseous syndrome and amelogenesis imperfecta with taurodontism. [provided by RefSeq, Jul 2008]
Show more UniProt Comments for DLX3
DLX3: Likely to play a regulatory role in the development of the ventral forebrain. May play a role in craniofacial patterning and morphogenesis. Defects in DLX3 are a cause of trichodentoosseous syndrome (TDO). TDO is an autosomal dominant syndrome characterized by enamel hypoplasia and hypocalcification with associated strikingly curly hair. Defects in DLX3 are the cause of amelogenesis imperfecta type 4 (AI4); also known as amelogenesis imperfecta hypomaturation-hypoplastic type with taurodontism. AI4 is an autosomal dominant defect of enamel formation associated with enlarged pulp chambers. Belongs to the distal-less homeobox family.
Protein type: DNA-binding; Transcription factor
Chromosomal Location of Human Ortholog: 17q21
Cellular Component: nucleus
Molecular Function: sequence-specific DNA binding; chromatin binding; transcription factor activity
Biological Process: blood vessel development; positive regulation of transcription from RNA polymerase II promoter; placenta development; odontogenesis of dentine-containing teeth
Disease: Amelogenesis Imperfecta, Type Iv; Trichodentoosseous Syndrome
Show more Protein type: DNA-binding; Transcription factor
Chromosomal Location of Human Ortholog: 17q21
Cellular Component: nucleus
Molecular Function: sequence-specific DNA binding; chromatin binding; transcription factor activity
Biological Process: blood vessel development; positive regulation of transcription from RNA polymerase II promoter; placenta development; odontogenesis of dentine-containing teeth
Disease: Amelogenesis Imperfecta, Type Iv; Trichodentoosseous Syndrome
Precautions
All of MyBioSource's Products are for scientific laboratory research purposes and are not for diagnostic, therapeutics, prophylactic or in vivo use. Through your purchase, you expressly represent and warrant to MyBioSource that you will properly test and use any Products purchased from MyBioSource in accordance with industry standards. MyBioSource and its authorized distributors reserve the right to refuse to process any order where we reasonably believe that the intended use will fall outside of our acceptable guidelines.
Disclaimer
While every efforts were made to ensure the accuracy of the information provided in this datasheet, MyBioSource will not be liable for any omissions or errors contained herein. MyBioSource reserves the right to make changes to this datasheet at any time without prior notice.
It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.
It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.
Product Note
Select online data sheet information is drawn from bioinformatics databases, occasionally resulting in ambiguous or non-relevant product information. It is the responsibility of the customer to review, verify, and evaluate the information to make sure it matches their requirements before purchasing the kit. Our ELISA Kit assays are dynamic research tools and sometimes they may be updated and improved. If the format of this assay is important to you then please request the current manual or contact our technical support team with a presales inquiry before placing an order. We will confirm the current details of the assay. We cannot guarantee the sample manual posted online is the most current manual, it is intended to serve as an example only. Please refer to the instructions For Use provided with the assay kit for precise details.
Product PubMed Publications
Diseases associated with anti-DLX3 antibody
| Disease Name | Pubmed Publications |
|---|---|
| Neoplasms Antibodies | >12 publications with DLX3 and Neoplasms |
| Pregnancy Complications Antibodies | >5 publications with DLX3 and Pregnancy Complications |
| Carcinoma Antibodies | >4 publications with DLX3 and Carcinoma |
| Abnormalities, Drug-Induced Antibodies | >2 publications with DLX3 and Abnormalities, Drug-Induced |
| Fetal Death Antibodies | >2 publications with DLX3 and Fetal Death |
| Premature Birth Antibodies | >1 publications with DLX3 and Premature Birth |
| Hyperplasia Antibodies | >1 publications with DLX3 and Hyperplasia |
| Drug Toxicity Antibodies | >1 publications with DLX3 and Drug Toxicity |
| Cardiovascular Diseases Antibodies | >1 publications with DLX3 and Cardiovascular Diseases |
Organs/Tissues associated with anti-DLX3 antibody
| Organ/Tissue Name | Pubmed Publications |
|---|---|
| Placenta Antibodies | >23 publications with DLX3 and Placenta |
| Embryonic Tissue Antibodies | >20 publications with DLX3 and Embryonic Tissue |
| Mouth Antibodies | >14 publications with DLX3 and Mouth |
| Connective Tissue Antibodies | >12 publications with DLX3 and Connective Tissue |
| Brain Antibodies | >10 publications with DLX3 and Brain |
| Eye Antibodies | >3 publications with DLX3 and Eye |
| Heart Antibodies | >2 publications with DLX3 and Heart |


